2017-18 Annual Report Summary

D&A Report Shows Heroin/Opiates Still Top List of Substance Abuse

HONESDALE (March 22, 2019) – While the overall number of inpatient referrals increased during the 2016-17 fiscal year, the percentage of heroin-opioid related admissions dropped slightly from 71 to 66 percent. According to the Wayne County Drug & Alcohol Commission’ annual report, heroin and opiates still outranked alcohol among primary substances abused, however methamphetamine use, while still low, has nearly doubled.

CERTIFIED PREVENTION SPECIALISTA pie graph showing Primary Substances abused by those presenting to the Wayne County Drug & Alcohol

The Wayne County Drug and Alcohol Commission's annual report provides a detailed look at the County office, its accomplishments, and the individuals it served during state fiscal year 2016-17.

During the year, the Drug and Alcohol Commission’s Certified Prevention Specialist staff served a total of 1,775 students via school-based support groups and classroom programs at the elementary, middle and high school levels. There were also two evidence-based parenting programs delivered by prevention staff.

In 2016-17 the Wayne County Drug and Alcohol Commission employed a full-time Certified Recovery Specialist (CRS). A CRS is a professional that has years of lived recovery experience who works closely with people who are new to recovery to increase their likelihood of success. Clients/consumers work with the CRS to develop an individualized recovery plan which focuses on the non-treatment needs that can create barriers to their recovery and lead to relapse. A total of 302 appointments were attended by individuals in recovery in 2016/17 and there were 48 new admissions.


The Case Management Unit completed a total of 688 screenings and 557 comprehensive assessments for clients seeking assistance including inmates at the Wayne County Correctional Facility. There were 115 clients referred by the Case Management Unit to inpatient treatment up 26 from fiscal year 2015/16.

Heroin and opiate use continue to account for the largest percentage of all inpatient admissions; 66% of inpatient admissions were heroin/opiate related, down slightly from 71% in 2015/16. There were 399 clients referred by Case Management to outpatient treatment. These clients were monitored every 60 days to assess the appropriateness of outpatient care being offered.

Primary substance trends remained consistent with the 2015/16 fiscal year. The 2016/17 fiscal year continued to see more individuals reporting heroin/opiates than alcohol as their primary substance. In 2016/17, 41% of the total clients served reported heroin/opiates as their primary substance. In 2015/16, that number was 43%. Also noteworthy, while the overall percentage remains low, methamphetamine use has nearly doubled this year to last.


The Medication Assisted Treatment (MAT) program utilizes two specific medications Suboxone, which is a partial opiate agonist, and Vivitrol, which is an opiate antagonist. Both are designed to assist people in the recovery process from heroin and other opiates by reducing intense cravings to use, which may otherwise interfere with successful engagement in treatment and other community recovery supports.

The Wayne County Drug and Alcohol Commission’s philosophy on MAT is that medication is only a recovery tool and is never considered to be a stand-alone treatment. Thus, being actively engaged in drug and alcohol treatment and other recovery related activities is a program requirement along with random urine drug screens, and random film counts.

The Wayne County Drug and Alcohol Commission contracts with Dr. Gary Good, a member of the Upper Delaware Valley Infectious Disease Practice of Monticello, New York, to oversee all medical aspects of the program, and as such he meets with all program participants a minimum of two times per month.

The MAT Program had 57 referrals and 29 new admissions in 2016/17 The program is long-term and highly individualized, therefore most people are involved in it one year or more.

D&A 2017-18 Annual Report